The Psychopathology and Allostatic load across the Life Span (PALS) network is a network of international academic centers that have come together to transform windows of vulnerability to mental and physical disorders into windows of neuroscientific advancement with diagnostic and therapeutic implications.
To view the full mission statement, click here. To learn more about the aims and goals of PALS, the different academic sites, and current events and projects, please explore the tabs located in the sidebar.
August 2018 - Congratulations to Drs. Rasgon, Singh, Frangou, and McIntyre for "which was recently accepted in the Behavioral Brain Research.
"The purpose of this double-blinded, placebo-controlled study was to examine the neural effects of administration of liraglutide in cognitively normal late middle-aged individuals with subjective cognitive complaints."
August 2018 - Congratulations to Drs. Nasca, Rasgon and McEwen, and Betty Bigio for "Acetyl-L-carnitine deficiency in patients with major depressive disorder" which was published in PNAS.
"The lack of biomarkers to identify target populations greatly limits the promise of precision medicine for major depressive disorder (MDD), a primary cause of ill health and disability."
July 2018: Dr. McIntosh is fundraising for MQ, a British charity that supports research both in the US and the UK. Please help him reach his fundraising target by donating at this link.
August 2018: We are excited to announce that, under Dr. Nemeroff's leadership, Dell Med is launching the Institute for Early Life Adversity Research as part of the Mulva Clinic for the Neurosciences.